Sex and Ethnic Differences in 47 Candidate Proteomic Markers of Cardiovascular Disease: The Mayo Clinic Proteomic Markers of Arteriosclerosis Study
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cardiovascular disease (CVD) susceptibility differs between men and women and varies with ethnicity. This variability is not entirely explained by conventional CVD risk factors. We examined differences in circulating levels of 47 novel protein markers of CVD in 2561 men and women of African-American (AA) and non-Hispanic White (NHW) ethnicity, enrolled at geographically distinct sites. METHODOLOGY/PRINCIPAL FINDINGS: Participants (1,324 AAs, mean age 63.5 y, 71% women; 1,237 NHWs, mean age 58.9 y, 57% women) belonged to sibships ascertained on the basis of hypertension. Solid-phase immunoassays and immunoturbidometric, clot-based, chromogenic, and electrophoretic assays were used to measure the 47 protein markers in plasma or serum. Marker levels were log transformed and outliers were adjusted to within 4 SD. To identify markers independently associated with sex or ethnicity, we employed multivariable regression analyses that adjusted for conventional risk factors, prior history of CVD, medication use and lifestyle factors (physical activity, alcohol consumption and education). Generalized estimating equations were used to correct for intrafamilial correlations. After adjustment for the above covariates, female sex was associated with higher levels of 29 markers and lower levels of 6 markers. Female sex was independently associated with higher levels of several inflammatory markers as well as lipoproteins, adipokines, natriuretic peptides, vasoconstrictor peptides and markers of calcification and thrombosis. AA ethnicity was associated with higher levels of 19 markers and lower levels of 6 markers, including higher levels of several inflammatory makers, higher leptin and lower adiponectin levels, lower levels of vasodilator-natriuretic peptides, higher levels of vasoconstrictor-antidiuretic peptides and markers of calcification and thrombosis. CONCLUSIONS/SIGNIFICANCE: Plasma levels of several novel protein markers of CVD differ significantly in the context of sex and ethnicity. These results have implications for individualized CVD risk assessment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290 · cited 1×
“Algorithms based on several established risk factors are used in the clinical setting for stratifying the risk of cardiovascular disease (CVD) in asymptomatic individuals [1,2,3,4].”
BackgroundAssmann, G., Cullen, P., & Schulte, H. (2002) · Circulation · doi:10.1161/hc0302.102575 · Cited by 1,541 · cited 1×
“Algorithms based on several established risk factors are used in the clinical setting for stratifying the risk of cardiovascular disease (CVD) in asymptomatic individuals [1,2,3,4].”
BackgroundHistory of the Rochester Epidemiology Project
Melton, L. J. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.3.266 · Cited by 1,443 · cited 2×
“The sampling frame of the Rochester GENOA cohort was the Mayo Clinic diagnostic index and medical record linkage system of the Rochester Epidemiology Project [16].”
MethodMeasurement of midregional proadrenomedullin in plasma with an immunoluminometric assay
Morgenthaler, N. G., Struck, J., Alonso, C., & Bergmann, A. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.051110 · Cited by 399 · cited 3×
“MRproADM, CT-proAVP, CT-proET, and MR-proANP were measured as part of a research collaboration with BRAHMS AG (Henningsdorf, Germany).”
MethodKnopp, R. H., Paramsothy, P., Retzlaff, B. M., Fish, B., Walden, C., Dowdy, A., Tsunehara, C., Aikawa, K., & Cheung, M. C. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0065-6 · Cited by 148
Estrogen, natriuretic peptides and the renin-angiotensin system.
Kuroski de Bold, M. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00324-1 · Cited by 122 · cited 1×
“. Another potential explanation is that women have lower plasma levels of renin, known to be inversely associated with natriuretic peptide levels”
BackgroundShort-term exposure to air pollution and inflammation-sensitive biomarkers
Steinvil, A., Kordova-Biezuner, L., Shapira, I., Berliner, S., & Rogowski, O. (2008) · Environmental Research · doi:10.1016/j.envres.2007.08.006 · Cited by 120 · cited 1×
“There are sparse data in the literature regarding geographic differences in biomarker levels, although environmental differences linked to pollution exposure appear to influence circulating levels of inflammatory markers [69,70].”
BackgroundRomero-Corral, A., Sierra-Johnson, J., Lopez-Jimenez, F., Thomas, R. J., Singh, P., Hoffmann, M., Okcay, A., Korinek, J., Wolk, R., & Somers, V. K. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1218 · Cited by 77 · cited 1×
“Higher leptin levels have been reported to be more strongly associated with CVD in women than in men [38].”
Background
Cited by
Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among 7 Ethnic Groups
Paré, G., Çaku, A., McQueen, M., Anand, S. S., Enas, E., Clarke, R., Boffa, M. B., Koschinsky, M., Wang, X., Yusuf, S., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.034311 · Cited by 382
Mirza, S., Hossain, M., Mathews, C., Martinez, P., Pino, P., Gay, J. L., Rentfro, A., McCormick, J. B., & Fisher-Hoch, S. P. (2012) · Cytokine · doi:10.1016/j.cyto.2011.09.029 · Cited by 358
“Elevated levels of IL-6 in both poorly controlled diabetes and well-controlled diabetes are well studied in other ethnic groups [13,15,22].”
Midlife Systemic Inflammation Is Associated With Frailty in Later Life: The ARIC Study
Walker, K. A., Walston, J., Gottesman, R. F., Kucharska-Newton, A., Palta, P., & Windham, B. G. (2019) · The Journals of Gerontology: Series A · doi:10.1093/gerona/gly045 · Cited by 91
Jiang, Y., Uhm, H., Ip, F. C., Ouyang, L., Lo, R. M. N., Cheng, E. Y. L., Cao, X., Tan, C. M. C., Law, B. C. H., Ortiz‐Romero, P., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13676 · Cited by 36
Metadata
- Authors
- Kim, C. X., Bailey, K. R., Klee, G. G., Ellington, A. A., Liu, G., Mosley, T. H., Rehman, H., & Kullo, I. J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-02-05
- Volume
- 5
- Issue
- 2
- Pages
- e9065
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2030735640
- Cited by
- 90
- References
- 8
- FWCI
- 6.74
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.